hit counter
Anthem, Inc. (ANTM) Stock News Sentiment & Price - Sentifly
ANTM - Sentifly



Your watchlist is empty. Go add some tickers to it!

Anthem, Inc. (ANTM)

Health Care Plans
ANTM Price and Sentiment
Positive, Negative
Loading chart...
ANTM Latest news
Zacks Investment Research
Anthem (ANTM) to Acquire Integra to Enhance Medicaid Business
2021-11-11 11:28

Anthem (ANTM) to buy Integra Managed Care from a wholly-owned indirect unit of Personal Touch Holding Corporation to bolster its Medicaid Business profile.

Business Wire
Anthem, Inc. to acquire Integra Managed Care
2021-11-10 08:00

INDIANAPOLIS--(BUSINESS WIRE)---- $ANTM--Anthem, Inc. (NYSE: ANTM) today announced that the company has entered into an agreement to acquire Integra Managed Care, a Managed Long-Term Care Plan in New York that helps adults with long term care needs and disabilities live safely and independently in their own home. Integra currently serves 40,000 Medicaid members who benefit from a dedicated care management team that includes a Registered Nurse, Social Worker, and Coordinator who work in partnership with m

Business Wire
Anthem Announces Appearance at Upcoming Conferences
2021-11-05 16:05

INDIANAPOLIS--(BUSINESS WIRE)--Anthem, Inc. (NYSE: ANTM) announced today that senior management is scheduled to present at the 30th Annual Credit Suisse Healthcare Conference on November 11, 2021 at 8:00 a.m. Eastern Standard Time (EST). Senior management is also scheduled to present at the Wolfe Research Virtual Healthcare Conference on November 17, 2021 at 8:00 a.m. Eastern Standard Time (EST). All interested parties are invited to listen to a webcast of these presentations by visiting www.an

Business Wire
Somatus and Anthem, Inc. Collaborate to Deliver Personalized, Value-Based Kidney Care
2021-11-03 08:00

MCLEAN, Va.--(BUSINESS WIRE)---- $ANTM #CKD--Somatus, a market leader in value-based kidney care, today announced a long-term, multi-year partnership with Anthem, Inc (NYSE: ANTM). Together, Anthem and Somatus will change how kidney care is experienced and delivered for members of Anthem's affiliated Medicare Advantage plans, specifically individuals with chronic kidney disease (CKD) Stage 3, 4, and 5 and end-stage kidney disease (ESKD). Somatus' services are available to eligible CKD and ESKD members enrolle

Zacks Investment Research
4 Healthcare Stocks to Top Q3 Estimates Amid Coronavirus Woes
2021-10-26 11:51

Factors like an aging populace and demand for products and services are likely to reflect on the Q3 results of ACAD, MD, ACHC and VRTX.

Seeking Alpha
Anthem, Inc. (ANTM) CEO Gail Boudreaux on Q3 2021 Results - Earnings Call Transcript
2021-10-20 13:27

Anthem, Inc. (ANTM) CEO Gail Boudreaux on Q3 2021 Results - Earnings Call Transcript

Zacks Investment Research
Anthem (ANTM) Q3 Earnings and Revenues Surpass Estimates
2021-10-20 10:10

Anthem (ANTM) delivered earnings and revenue surprises of 6.93% and 0.60%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research
Anthem's (ANTM) Q3 Earnings Beat Estimates, Increase Y/Y
2021-10-20 10:09

Anthem's (ANTM) third-quarter results reflect higher revenues and solid contribution from its segments.

Anthem Q3 Earnings Beat Estimates, Raises FY21 EPS Outlook
2021-10-20 06:46

Anthem Inc (NYSE: ANTM) has reported Q3 adjusted earnings of $6.79 per share, beating the consensus of $6.39. Operating revenue rose 16% to $35.5 billion, slightly topping expectations of $35.3 billion, driven by higher premium revenue due to growth in Medicaid and Medicare and pharmacy product revenue related to IngenioRx.

Market Watch
Anthem stock gains after profit and revenue beats, raised full-year earnings outlook
2021-10-20 06:19

Shares of Anthem Inc. ANTM, +1.43% rose 0.6% in premarket trading Wednesday, after the health benefits company reported third-quarter profit and revenue that rose above expectations, amid higher premium revenue due to growth in Medicaid and Medicare, and raised its full-year outlook. Net income rose nearly seven-fold to $1.51 billion, or $6.13 a share, from $222 million, or 87 cents a share, in the year-ago period.

Loading more news...